Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-28.00	43.61	60.57
Graham Fair Price	21.59	9.28	7.63
PEG	29.82	0.60	0.46
Price/Book	-13.25	8.52	9.82
Price/Cash Flow	-86.82	36.31	275.46
Prices/Earnings	-28.80	20.51	28.80
Price/Sales	-24.15	8.63	11.38
Price/FCF	-86.82	36.31	275.46
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	181.87	0.50	0.18
Operating Margin	7.75	0.17	0.16
ROA	18.34	0.05	0.04
ROE	0.09	0.10	21.84
ROIC	0.09	0.10	15.02
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.10	-0.13	27.02
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.54	0.36	-33.59
EPS QOQ	0.62	0.34	-45.15
FCF QOQ	-0.79	6.25	689.96
Revenue QOQ	0.18	0.26	43.60
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	7.56	12.85	69.92
Days Sales Outstanding (DSO)	45.96	39.34	-14.41
Inventory Turnover	11.91	7.01	-41.15
Debt/Capitalization	0.12	0.14	22.27
Quick Ratio	0.94	1.04	10.93
Naive Interpretation	member

04 - Leverage & Liquidity · Balanced

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	5.51	6.07	10.15
Cash	1.48	2.65	79.71
Capex	0.09	-0.09	1.64
Free Cash Flow	0.20	1.42	625.03
Revenue	4.75	5.99	26.00
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.17	1.25	7.38
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-0.38	-1.41	-273.14
Naive Interpretation	Member

06 - Financial Health · Weak

Rating